Skip to main content
All lobbying filings

BLUECROSS BLUESHIELD OF TENNESSEE

Lobbying for BLUECROSS BLUESHIELD OF TENNESSEE

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate · $140,000.00 expenses · posted Jul 18, 2026

Official filing document

 Bills named in this filing 19
  • S 2355
    Patients Deserve Price Tags Act
  • HR 4710
    No Surprises Act Enforcement Act
  • S 2420
    No Surprises Act Enforcement Act
  • S 4027
    Healthy Competition for Better Care Act
  • HR 6248
    Healthy Competition for Better Care Act
  • HR 2079
    Insurance Fraud Accountability Act
  • HR 8684
    Transparency in Billing Act of 2026
  • HR 9393
    Lower Costs, More Transparency Act of 2026
  • S 1105
    No UPCODE Act
  • HR 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • 119-HR-93932
    Not yet in our database
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 8871
    DME Scammer Prevention Act of 2026
  • S 3762
    Prior Authorization Relief Act
  • S 3014
    Ensuring Timely Access to Generics Act of 2025
  • S 1040
    Drug Competition Enhancement Act
  • S 1095
    Stop STALLING Act
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
  • HR 4570
    Interagency Patent Coordination and Improvement Act of 2025
 Lobbying activity 3
Health Issues

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Federal Budget Process; Hospital Billing/Consolidation; Maternal Health; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Health Savings Accounts; Suprise Billing; Artificial Intelligence S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes. H.R. 8684 - Transparency in Billing Act of 2026 To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 9393 - Lower Costs, More Transparency Act of 2026 To promote price transparency in the health care sector

Medicare/Medicaid

Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform; Program Fraud Waste and Abuse S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington H.R. 93932 - Medicare Advantage Cost Transparency Act To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data. H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 To amend Title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. H.R. 8871 - DME Scammer Prevention Act of 2026 To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies. S. 3762 - Prior Authorization Relief Act To amend part C of the title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.

Pharmacy

Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem